Ownership history in UBS Group AG · 4 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CONDUIT PHARMACEUTICALS INC (CDTTW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 622 | -3,090 | -83.2% | 0.00% | $7 | — |
| 2025 Q1 | ADDED | 3,712 | +3,196 | +619.4% | 0.00% | $33 | — |
| 2024 Q3 | REDUCED | 516 | -5,676 | -91.7% | 0.00% | $6 | — |
| 2023 Q3 | INITIATED | 6,192 | — | — | 0.00% | $279 | — |
As of 2025 Q4 — sorted by position size